IKT
Inhibikase Therapeutics Inc
NASDAQ: IKT · HEALTHCARE · BIOTECHNOLOGY
$1.93
-0.52% today
Updated 2026-05-05
Market cap
$254.82M
P/E ratio
—
P/S ratio
10.39x
EPS (TTM)
$-0.49
Dividend yield
—
52W range
$1 – $2
Volume
1.4M
Inhibikase Therapeutics Inc (IKT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $967386.00 | $2.06M | $4.04M | $1.12M | $698468.00 | $3.10M | $123440.00 | $260500.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +113.0% | +96.1% | -72.2% | -37.8% | +343.9% | -96.0% | +111.0% | -100.0% | — |
| Cost of revenue | $846386.00 | $1.76M | $3.65M | $2.55M | $893802.00 | $11.36M | $6723.00 | $13.62M | $26272.00 | $60499.00 |
| Gross profit | $121000.00 | $305245.00 | $4.04M | $-1.43M | $698468.00 | $3.10M | $116717.00 | $-13.36M | $-26272.00 | $-60499.00 |
| Gross margin | 12.5% | 14.8% | 100.0% | -127.4% | 100.0% | 100.0% | 94.6% | -5127.8% | — | — |
| R&D | $846386.00 | $1.76M | $3.65M | $2.55M | $893802.00 | $11.36M | $12.03M | $13.62M | $17.21M | $29.79M |
| SG&A | — | — | $2.52M | $4.27M | $2.62M | $6.51M | $6.22M | $6.68M | $11.38M | $23.56M |
| Operating income | $-613288.00 | $-405130.00 | $-2.12M | $-5.70M | $-2.82M | $-14.77M | $-18.13M | $-20.09M | $-28.59M | $-45.95M |
| Operating margin | -63.4% | -19.7% | -52.5% | -507.5% | -403.5% | -476.2% | -14686.2% | -7712.0% | — | — |
| EBITDA | — | — | $-2.12M | $-5.70M | $-2.82M | $-14.77M | $-18.05M | $-19.91M | $-27.49M | $-45.89M |
| EBITDA margin | 0.0% | 0.0% | -52.5% | -507.5% | -403.5% | -476.2% | -14620.4% | -7643.9% | — | — |
| EBIT | $-613288.00 | $-405130.00 | $-2.12M | $-5.70M | $-2.82M | $-14.77M | $-18.05M | $-20.09M | $-27.52M | $-45.95M |
| Interest expense | $0.00 | $0.00 | $30332.00 | $24835.00 | $29402.00 | $19923.00 | $74453.00 | $74453.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-628737.00 | $-436075.00 | $-2.15M | $-5.75M | $-2.88M | $-14.81M | $-18.05M | $-19.03M | $-27.52M | $-48.26M |
| Net income growth (YoY) | — | +30.6% | -393.6% | -167.0% | +49.9% | -414.6% | -21.9% | -5.4% | -44.6% | -75.4% |
| Profit margin | -65.0% | -21.2% | -53.3% | -511.9% | -411.9% | -477.5% | -14625.9% | -7304.8% | — | — |